 American Renal Associates NYSE:ARA was downgraded by equities research analysts at ValuEngine from a buy rating to a hold rating in a research note issued to investors on Tuesday, ValuEngine reports. Several other equities research analysts have also commented on ARA. SunTrust Banks boosted their price target on American Renal Associates from 9.00 to 11.00 ... 